Infections by multidrug resistant organisms (MDROs) are a global health threat with a worrying increasing trend. In fragile ...

Multidrug-resistant (MDR) A. baumannii is a rapidly emerging pathogen in healthcare settings, where it causes infections that include bacteremia, pneumonia, meningitis, and urinary tract and wound ...

Studies show under-representation of children and teens with multidrug-resistant TB, calling for focused case-finding efforts ...

The following is a summary of “Carbapenemase production and in-hospital mortality associated with multidrug-resistant ...

Multidrug-resistance is a significant challenge in eliminating the bacterial disease, as the complication increases treatment ...

Disparate pathogenic mechanisms complicate precision-medicine efforts to treat diffuse large B-cell lymphoma (DLBCL), the most common lymphoma diagnosis. Though potentially curable with frontline ...

Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the ...

A tuberculosis (TB) patient is said to be multidrug-resistant when the bacteria strain causing the infection has become ...

Study finds three new safe and effective drug regimens to fight multidrug-resistant TB. The treatments, which include recently discovered TB drugs, give new options for shorter, personalized treatment ...

UCSF model shortens tuberculosis treatment by over three months through optimal combinations UCSF creates a groundbreaking approach to tuberculosis management by optimizing antibiotic therapies.

Kansas is experiencing its most significant tuberculosis outbreak, with 67 active and 79 latent cases reported in Wyandotte ...